High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival

British Journal of Haematology

Volumn 146, Issue 6, 2009, Pages 669-674

  Jacobsohn, David A ^a,b   Tse, William T ^a,b   Chaleff, Stanley ^c   Rademaker, Alfred ^b   Duerst, Reggie ^b   Olszewski, Marie ^a,b   Huang, Wei ^a,b   Chou, Pauline M ^a   Kletzel, Morris ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Maine Children's Cancer Program Portland   (United States)

Author keywords

Aml; Minimal residual disease; Paediatric; Stem cell transplantation; Wt1 gene expression

Indexed keywords

WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; DISEASE FREE SURVIVAL; FEMALE; GENETIC MARKER; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; METABOLISM; MINIMAL RESIDUAL DISEASE; MORTALITY; PREDICTION AND FORECASTING; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GENETIC MARKERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; TRANSPLANTATION CONDITIONING; WT1 PROTEINS;

EID: 77449153312     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07770.x     Document Type: Article

References (21)

1. Campana, D. (2008) Status of minimal residual disease testing in childhood haematological malignancies. British Journal of Haematology, 143, 481-489.
2. Campana, D. & Coustan-Smith, E. (1999) Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry, 38, 139-152.
3. Chaise, C., Buchan, S.L., Rice, J., Marquet, J., Rouard, H., Kuentz, M., Vittes, G.E., Molinier-Frenkel, V., Farcet, J.P., Stauss, H.J., Delfau-Larue, M.H. & Stevenson, F.K. (2008) DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance. Blood, 112, 2956-2964.
4. Cilloni, D., Gottardi, E., De Micheli, D., Serra, A., Volpe, G., Messa, F., Rege-Cambrin, G., Guerrasio, A., Divona, M., Lo, C.F. & Saglio, G. (2002) Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia, 16, 2115-2121.
5. Coppes, M.J., Campbell, C.E. & Williams, B.R. (1993) The role of WT1 in Wilms tumorigenesis. FASEB Journal, 7, 886-895.
6. Jacobsohn, D.A., Hewlett, B., Ranalli, M., Seshadri, R., Duerst, R. & Kletzel, M. (2004) Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia. Bone Marrow Transplantation, 34, 901-907.
7. Kletzel, M., Olzewski, M., Huang, W. & Chou, P.M. (2002) Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia. Pediatric Developmental Pathology, 5, 269-275.
8. Kletzel, M., Jacobsohn, D. & Duerst, R. (2006) Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 472-479.
9. Lapillonne, H., Renneville, A., Auvrignon, A., Flamant, C., Blaise, A., Perot, C., Lai, J.L., Ballerini, P., Mazingue, F., Fasola, S., Dehee, A., Bellman, F., Adam, M., Labopin, M., Douay, L., Leverger, G., Preudhomme, C. & Landman-Parker, J. (2006) High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. Journal of Clinical Oncology, 24, 1507-1515.
10. Menssen, H.D., Renkl, H.J., Rodeck, U., Maurer, J., Notter, M., Schwartz, S., Reinhardt, R. & Thiel, E. (1995) Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia, 9, 1060-1067.
11. Olszewski, M., Huang, W., Chou, P.M., Duerst, R. & Kletzel, M. (2005) Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?. Cytotherapy, 7, 57-61.
12. Ommen, H.B., Nyvold, C.G., Braendstrup, K., Andersen, B.L., Ommen, I.B., Hasle, H., Hokland, P. & Ostergaard, M. (2008) Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals. British Journal of Haematology, 141, 782-791.
13. Ostergaard, M., Olesen, L.H., Hasle, H., Kjeldsen, E. & Hokland, P. (2004) WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study. British Journal of Haematology, 125, 590-600.
14. Ozgen, U., Anak, S., Ozbek, U., Sarper, N., Eryilmaz, E., Agaoglu, L., Devecioglu, O., Yalman, N. & Gedikoglu, G. (2000) Wt1 gene expression in childhood acute leukemias. Acta Haematologica, 103, 229-230.
15. Papadaki, C., Dufour, A., Seibl, M., Schneider, S., Bohlander, S.K., Zellmeier, E., Mellert, G., Hiddeman, W. & Spiekermann, K. (2008) Monitoring minimal residual diseae in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor. British Journal of Haematology, 144, 517-523.
16. Pulsipher, M.A., Bader, P., Klingebiel, T. & Cooper, L.J. (2008) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/ chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Biology of Blood and Marrow Transplantation, 15, 62-71.
17. Raanani, P. & Ben-Bassat, I. (2004) Detection of minimal residual disease in acute myelogenous leukemia. Acta Haematologica, 112, 40-54.
18. Trka, J., Kalinova, M., Hrusak, O., Zuna, J., Krejci, O., Madzo, J., Sedlacek, P., Vavra, V., Michalova, K., Jarosova, M. & Stary, J. (2002) Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia, 16, 1381-1389.
19. Virappane, P., Gale, R., Hills, R., Kakkas, I., Summers, K., Stevens, J., Allen, C., Green, C., Quentmeier, H., Drexler, H., Burnett, A., Linch, D., Bonnet, D., Lister, T.A. & Fitzgibbon, J. (2008) Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party. Journal of Clinical Oncology 26, 5429-5435.
20. Woods, W.G., Kobrinsky, N., Buckley, J.D., Lee, J.W., Sanders, J., Neudorf, S., Gold, S., Barnard, D.R., DeSwarte, J., Dusenbery, K., Kalousek, D., Arthur, D.C. & Lange, B.J. (1996) Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood, 87, 4979-4989.
21. Woods, W.G., Neudorf, S., Gold, S., Sanders, J., Buckley, J.D., Barnard, D.R., Dusenbery, K., DeSwarte, J., Arthur, D.C., Lange, B.J. & Kobrinsky, N.L. (2001) A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood, 97, 56-62.